CNBC

Tempus Founder and CEO, Eric Lefkofsky, discusses how generative AI is more impactful in healthcare diagnostics

Feb 17, 2025

Media Coverage

Related content

Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling

Tempus Expands Strategic Collaboration with Bristol Myers Squibb

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC